Generics

Business Development and Partnerships

Mylan is the third largest generics and specialty pharmaceutical company in the world, providing products to customers in more than 140 countries and territories and having a global manufacturing capacity of more than 45 billion doses. Through Dey, our specialty business, we are a leader in the respiratory and allergy markets and have a focus in the CNS sector. Mylan subsidiaries UDL and Mylan Technologies hold leadership positions in unit dose packaging and transdermal drug delivery systems, respectively. Through our Matrix subsidiary, we are one of the world's largest active pharmaceutical ingredients (API) manufacturers and one of the world's largest producers of API used to make generic antiretroviral therapies for the treatment of HIV/AIDS.

If you believe you have a business opportunity or potential collaboration idea, please let us know by filling out the form below. We will respond to your inquiry as soon as possible.

First Name *

Last Name *

Title *

Company *

Address 1

Address 2

City

Country *

Postal Code

E-mail Address *

Phone *

Fax

Summary Description of Potential Opportunity *

(2,000 character limit)

Type of Product or Opportunity

(check one)

Geography

(check all that apply)

North America

Latin or South America

Europe, Middle East or Africa

Asia-Pacific

Verification Code *

Match the characters

* Required Fields